Which antiarrhythmic drug to choose after electrical cardioversion: A study on non-valvular atrial fibrillation patients.
The relative efficacy of antiarrhythmic drugs (AADs) after electrical cardioversion are not well established. This study aimed to investigate the efficacies of different AADs for maintaining sinus rhythm (SR) after electrical cardioversion for atrial fibrillation (AF). We selected patients from a re...
Main Authors: | Hye Bin Gwag, Kwang Jin Chun, Jin Kyung Hwang, Seung-Jung Park, June Soo Kim, Kyoung-Min Park, Young Keun On |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5963785?pdf=render |
Similar Items
-
Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation
by: N. A. Novikova, et al.
Published: (2016-11-01) -
Outcomes of cardiac resynchronization therapy in patients with atrial fibrillation accompanied by slow ventricular response.
by: Jin Kyung Hwang, et al.
Published: (2019-01-01) -
Comparison of antiarrhythmic medications propafenone and amiodarone injection forms effectiveness in medicamentous cardioversion of paroxysmal atrial fibrillation
by: Aleksei V. Tarasov, et al.
Published: (2019-01-01) -
Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter
by: E B Maĭkov, et al.
Published: (2015-01-01) -
LA volume index as a predictor of successful electrical cardioversion and recurrence of atrial fibrillation in patients with non valvular atrial fibrillation
by: Muhammed Mustthafa
Published: (2020-11-01)